This inventor holds 1 USPTO granted patent. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Immunoforge Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 1 Years Active: 2026
Title: Sion Lee: Inventor in Cancer Research
Introduction
Sion Lee is an inventor associated with Daegu, South Korea. His patent work concerns a potential cancer treatment compound designed to inhibit specific kinases involved in cancer-cell growth.
Latest Patents
Lee is associated with 1 patent: “3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)-N-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer.” The invention describes a compound, a method for preparing it, and a pharmaceutical composition intended to prevent or treat cancer. According to the patent description, the derivative can inhibit cancer-cell proliferation by targeting kinases, particularly Bcr-Abl and Bcr-Abl (T315I).
Career Highlights
Lee’s listed organizational affiliations include the Daegu-Gyeongbuk Medical Innovation Foundation and Immunoforge Co., Ltd. His patent work reflects a focus on pharmaceutical research and potential cancer therapies.
Collaborations
Lee’s listed coworkers include Doohyun Lee and Seungyeon Lee. Their names appear among his professional collaborators associated with this area of research.
Conclusion
Sion Lee’s patent activity centers on a kinase-inhibiting compound with potential applications in cancer prevention or treatment, connecting his work to pharmaceutical innovation in South Korea.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile